HEADER HYDROLASE/HYDROLASE INHIBITOR 29-JUL-21 7RN7 TITLE CRYSTAL STRUCTURE OF CASPASE-3 WITH INHIBITOR AC-VD(ALY)VD-CHO COMPND MOL_ID: 1; COMPND 2 MOLECULE: CASPASE-3 SUBUNIT P17; COMPND 3 CHAIN: A, C; COMPND 4 ENGINEERED: YES; COMPND 5 MOL_ID: 2; COMPND 6 MOLECULE: CASPASE-3 SUBUNIT P12; COMPND 7 CHAIN: B, D; COMPND 8 ENGINEERED: YES; COMPND 9 MOL_ID: 3; COMPND 10 MOLECULE: AC-VD(ALY)VD-CHO; COMPND 11 CHAIN: F, G; COMPND 12 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: CASP3, CPP32; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21(DE3); SOURCE 7 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 8 MOL_ID: 2; SOURCE 9 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 10 ORGANISM_COMMON: HUMAN; SOURCE 11 ORGANISM_TAXID: 9606; SOURCE 12 GENE: CASP3, CPP32; SOURCE 13 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21(DE3); SOURCE 14 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 15 MOL_ID: 3; SOURCE 16 SYNTHETIC: YES; SOURCE 17 ORGANISM_SCIENTIFIC: SYNTHETIC CONSTRUCT; SOURCE 18 ORGANISM_TAXID: 32630 KEYWDS HYDROLASE/HYDROLASE INHIBITOR, HYDROLASE, HYDROLASE-HYDROLASE KEYWDS 2 INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR W.MCCUE,B.C.FINZEL REVDAT 4 15-NOV-23 7RN7 1 REMARK REVDAT 3 18-OCT-23 7RN7 1 REMARK REVDAT 2 09-FEB-22 7RN7 1 JRNL REVDAT 1 05-JAN-22 7RN7 0 JRNL AUTH M.BRESINSKY,J.M.STRASSER,B.VALLASTER,P.LIU,W.M.MCCUE, JRNL AUTH 2 J.FULLER,A.HUBMANN,G.SINGH,K.M.NELSON,M.E.CUELLAR, JRNL AUTH 3 C.M.WILMOT,B.C.FINZEL,K.H.ASHE,M.A.WALTERS,S.POCKES JRNL TITL STRUCTURE-BASED DESIGN AND BIOLOGICAL EVALUATION OF NOVEL JRNL TITL 2 CASPASE-2 INHIBITORS BASED ON THE PEPTIDE ACVDVAD-CHO AND JRNL TITL 3 THE CASPASE-2-MEDIATED TAU CLEAVAGE SEQUENCE YKPVD314. JRNL REF ACS PHARMACOL TRANSL SCI V. 5 20 2022 JRNL REFN ESSN 2575-910 JRNL PMID 35059567 JRNL DOI 10.1021/ACSPTSCI.1C00251 REMARK 2 REMARK 2 RESOLUTION. 2.40 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX 1.19.2 REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : GEOSTD + MONOMER LIBRARY + CDL V1.2 REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.40 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 43.28 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.350 REMARK 3 COMPLETENESS FOR RANGE (%) : 98.4 REMARK 3 NUMBER OF REFLECTIONS : 21694 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.191 REMARK 3 R VALUE (WORKING SET) : 0.188 REMARK 3 FREE R VALUE : 0.252 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.100 REMARK 3 FREE R VALUE TEST SET COUNT : 1107 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 43.2800 - 4.8000 0.97 2612 140 0.1733 0.2200 REMARK 3 2 4.8000 - 3.8100 0.96 2519 144 0.1457 0.1973 REMARK 3 3 3.8100 - 3.3300 0.99 2598 118 0.1733 0.2448 REMARK 3 4 3.3300 - 3.0200 0.99 2553 157 0.2117 0.2559 REMARK 3 5 3.0200 - 2.8100 0.99 2594 123 0.2277 0.3251 REMARK 3 6 2.8100 - 2.6400 1.00 2567 146 0.2263 0.3018 REMARK 3 7 2.6400 - 2.5100 0.99 2610 121 0.2222 0.3304 REMARK 3 8 2.5100 - 2.4000 0.98 2534 158 0.2276 0.3155 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.325 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 27.008 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 30.12 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.008 3885 REMARK 3 ANGLE : 1.078 5230 REMARK 3 CHIRALITY : 0.056 573 REMARK 3 PLANARITY : 0.006 670 REMARK 3 DIHEDRAL : 20.740 533 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 7RN7 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 30-JUL-21. REMARK 100 THE DEPOSITION ID IS D_1000258593. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 18-APR-21 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : APS REMARK 200 BEAMLINE : 17-ID REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.0 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS EIGER2 X 9M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : AUTOPROCESS REMARK 200 DATA SCALING SOFTWARE : AIMLESS 0.7.4 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 21724 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.400 REMARK 200 RESOLUTION RANGE LOW (A) : 52.490 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 98.6 REMARK 200 DATA REDUNDANCY : 3.000 REMARK 200 R MERGE (I) : 0.18200 REMARK 200 R SYM (I) : NULL REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 4.4000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.40 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.53 REMARK 200 COMPLETENESS FOR SHELL (%) : 98.5 REMARK 200 DATA REDUNDANCY IN SHELL : 2.80 REMARK 200 R MERGE FOR SHELL (I) : 0.51800 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 <I/SIGMA(I)> FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: 2H65 REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 50.71 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.50 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 16% PEG 6000, 5% GLYCEROL, 100 MM REMARK 280 SODIUM CITRATE PH 6.5, AND 10 MM DTT, VAPOR DIFFUSION, HANGING REMARK 280 DROP, TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 34.02050 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: HEXAMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: HEXAMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 15440 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 17090 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -87.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B, C, D, F, G REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 THR A 174 REMARK 465 CYS B 184 REMARK 465 HIS B 277 REMARK 465 HIS B 278 REMARK 465 ASP C 34 REMARK 465 CYS D 184 REMARK 465 HIS D 185 REMARK 465 HIS D 277 REMARK 465 HIS D 278 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 ASP A 34 CG OD1 OD2 REMARK 470 LYS A 57 CG CD CE NZ REMARK 470 GLU A 98 CG CD OE1 OE2 REMARK 470 LYS A 110 CG CD CE NZ REMARK 470 GLU A 167 CG CD OE1 OE2 REMARK 470 GLU A 173 CG CD OE1 OE2 REMARK 470 HIS B 185 CG ND1 CD2 CE1 NE2 REMARK 470 LYS B 229 CG CD CE NZ REMARK 470 TYR B 276 CG CD1 CD2 CE1 CE2 CZ OH REMARK 470 LYS C 57 CG CD CE NZ REMARK 470 LYS C 88 CG CD CE NZ REMARK 470 LYS C 105 CG CD CE NZ REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 LYS A 82 29.45 80.30 REMARK 500 CYS A 148 78.12 -114.52 REMARK 500 LYS B 229 -52.06 -136.12 REMARK 500 ARG C 64 78.00 -103.08 REMARK 500 LYS C 82 37.19 75.26 REMARK 500 ASP C 90 69.41 37.36 REMARK 500 ALA C 162 146.65 -177.20 REMARK 500 REMARK 500 REMARK: NULL REMARK 525 REMARK 525 SOLVENT REMARK 525 REMARK 525 THE SOLVENT MOLECULES HAVE CHAIN IDENTIFIERS THAT REMARK 525 INDICATE THE POLYMER CHAIN WITH WHICH THEY ARE MOST REMARK 525 CLOSELY ASSOCIATED. THE REMARK LISTS ALL THE SOLVENT REMARK 525 MOLECULES WHICH ARE MORE THAN 5A AWAY FROM THE REMARK 525 NEAREST POLYMER CHAIN (M = MODEL NUMBER; REMARK 525 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE REMARK 525 NUMBER; I=INSERTION CODE): REMARK 525 REMARK 525 M RES CSSEQI REMARK 525 HOH A 240 DISTANCE = 6.44 ANGSTROMS REMARK 525 HOH A 241 DISTANCE = 6.48 ANGSTROMS DBREF 7RN7 A 34 174 UNP P42574 CASP3_HUMAN 34 174 DBREF 7RN7 B 184 277 UNP P42574 CASP3_HUMAN 184 277 DBREF 7RN7 C 34 174 UNP P42574 CASP3_HUMAN 34 174 DBREF 7RN7 D 184 277 UNP P42574 CASP3_HUMAN 184 277 DBREF 7RN7 F 1 6 PDB 7RN7 7RN7 1 6 DBREF 7RN7 G 1 6 PDB 7RN7 7RN7 1 6 SEQADV 7RN7 HIS B 278 UNP P42574 EXPRESSION TAG SEQADV 7RN7 HIS D 278 UNP P42574 EXPRESSION TAG SEQRES 1 A 141 ASP ASN SER TYR LYS MET ASP TYR PRO GLU MET GLY LEU SEQRES 2 A 141 CYS ILE ILE ILE ASN ASN LYS ASN PHE HIS LYS SER THR SEQRES 3 A 141 GLY MET THR SER ARG SER GLY THR ASP VAL ASP ALA ALA SEQRES 4 A 141 ASN LEU ARG GLU THR PHE ARG ASN LEU LYS TYR GLU VAL SEQRES 5 A 141 ARG ASN LYS ASN ASP LEU THR ARG GLU GLU ILE VAL GLU SEQRES 6 A 141 LEU MET ARG ASP VAL SER LYS GLU ASP HIS SER LYS ARG SEQRES 7 A 141 SER SER PHE VAL CYS VAL LEU LEU SER HIS GLY GLU GLU SEQRES 8 A 141 GLY ILE ILE PHE GLY THR ASN GLY PRO VAL ASP LEU LYS SEQRES 9 A 141 LYS ILE THR ASN PHE PHE ARG GLY ASP ARG CYS ARG SER SEQRES 10 A 141 LEU THR GLY LYS PRO LYS LEU PHE ILE ILE GLN ALA CYS SEQRES 11 A 141 ARG GLY THR GLU LEU ASP CYS GLY ILE GLU THR SEQRES 1 B 95 CYS HIS LYS ILE PRO VAL GLU ALA ASP PHE LEU TYR ALA SEQRES 2 B 95 TYR SER THR ALA PRO GLY TYR TYR SER TRP ARG ASN SER SEQRES 3 B 95 LYS ASP GLY SER TRP PHE ILE GLN SER LEU CYS ALA MET SEQRES 4 B 95 LEU LYS GLN TYR ALA ASP LYS LEU GLU PHE MET HIS ILE SEQRES 5 B 95 LEU THR ARG VAL ASN ARG LYS VAL ALA THR GLU PHE GLU SEQRES 6 B 95 SER PHE SER PHE ASP ALA THR PHE HIS ALA LYS LYS GLN SEQRES 7 B 95 ILE PRO CYS ILE VAL SER MET LEU THR LYS GLU LEU TYR SEQRES 8 B 95 PHE TYR HIS HIS SEQRES 1 C 141 ASP ASN SER TYR LYS MET ASP TYR PRO GLU MET GLY LEU SEQRES 2 C 141 CYS ILE ILE ILE ASN ASN LYS ASN PHE HIS LYS SER THR SEQRES 3 C 141 GLY MET THR SER ARG SER GLY THR ASP VAL ASP ALA ALA SEQRES 4 C 141 ASN LEU ARG GLU THR PHE ARG ASN LEU LYS TYR GLU VAL SEQRES 5 C 141 ARG ASN LYS ASN ASP LEU THR ARG GLU GLU ILE VAL GLU SEQRES 6 C 141 LEU MET ARG ASP VAL SER LYS GLU ASP HIS SER LYS ARG SEQRES 7 C 141 SER SER PHE VAL CYS VAL LEU LEU SER HIS GLY GLU GLU SEQRES 8 C 141 GLY ILE ILE PHE GLY THR ASN GLY PRO VAL ASP LEU LYS SEQRES 9 C 141 LYS ILE THR ASN PHE PHE ARG GLY ASP ARG CYS ARG SER SEQRES 10 C 141 LEU THR GLY LYS PRO LYS LEU PHE ILE ILE GLN ALA CYS SEQRES 11 C 141 ARG GLY THR GLU LEU ASP CYS GLY ILE GLU THR SEQRES 1 D 95 CYS HIS LYS ILE PRO VAL GLU ALA ASP PHE LEU TYR ALA SEQRES 2 D 95 TYR SER THR ALA PRO GLY TYR TYR SER TRP ARG ASN SER SEQRES 3 D 95 LYS ASP GLY SER TRP PHE ILE GLN SER LEU CYS ALA MET SEQRES 4 D 95 LEU LYS GLN TYR ALA ASP LYS LEU GLU PHE MET HIS ILE SEQRES 5 D 95 LEU THR ARG VAL ASN ARG LYS VAL ALA THR GLU PHE GLU SEQRES 6 D 95 SER PHE SER PHE ASP ALA THR PHE HIS ALA LYS LYS GLN SEQRES 7 D 95 ILE PRO CYS ILE VAL SER MET LEU THR LYS GLU LEU TYR SEQRES 8 D 95 PHE TYR HIS HIS SEQRES 1 F 6 ACE VAL ASP ALY VAL ASP SEQRES 1 G 6 ACE VAL ASP ALY VAL ASP HET ACE F 1 3 HET ALY F 4 12 HET ACE G 1 3 HET ALY G 4 12 HETNAM ACE ACETYL GROUP HETNAM ALY N(6)-ACETYLLYSINE FORMUL 5 ACE 2(C2 H4 O) FORMUL 5 ALY 2(C8 H16 N2 O3) FORMUL 7 HOH *105(H2 O) HELIX 1 AA1 HIS A 56 GLY A 60 5 5 HELIX 2 AA2 GLY A 66 LEU A 81 1 16 HELIX 3 AA3 THR A 92 LYS A 105 1 14 HELIX 4 AA4 LEU A 136 PHE A 142 1 7 HELIX 5 AA5 CYS A 148 THR A 152 5 5 HELIX 6 AA6 TRP B 214 ALA B 227 1 14 HELIX 7 AA7 GLU B 231 PHE B 247 1 17 HELIX 8 AA8 ASP B 253 HIS B 257 5 5 HELIX 9 AA9 HIS C 56 GLY C 60 5 5 HELIX 10 AB1 GLY C 66 LEU C 81 1 16 HELIX 11 AB2 THR C 92 LYS C 105 1 14 HELIX 12 AB3 LEU C 136 PHE C 142 1 7 HELIX 13 AB4 CYS C 148 THR C 152 5 5 HELIX 14 AB5 TRP D 214 ALA D 227 1 14 HELIX 15 AB6 GLU D 231 PHE D 247 1 17 HELIX 16 AB7 ASP D 253 HIS D 257 5 5 SHEET 1 AA112 GLU A 84 ASN A 89 0 SHEET 2 AA112 GLU A 43 ASN A 51 1 N ASN A 51 O LYS A 88 SHEET 3 AA112 ARG A 111 LEU A 119 1 O VAL A 117 N ILE A 48 SHEET 4 AA112 LYS A 156 GLN A 161 1 O LEU A 157 N PHE A 114 SHEET 5 AA112 PHE B 193 TYR B 197 1 O LEU B 194 N PHE A 158 SHEET 6 AA112 CYS B 264 SER B 267 -1 O VAL B 266 N TYR B 195 SHEET 7 AA112 CYS D 264 SER D 267 -1 O SER D 267 N ILE B 265 SHEET 8 AA112 PHE D 193 TYR D 197 -1 N TYR D 195 O VAL D 266 SHEET 9 AA112 LYS C 156 GLN C 161 1 N PHE C 158 O LEU D 194 SHEET 10 AA112 ARG C 111 LEU C 119 1 N PHE C 114 O LEU C 157 SHEET 11 AA112 GLU C 43 ASN C 51 1 N ILE C 48 O VAL C 117 SHEET 12 AA112 GLU C 84 ASN C 89 1 O LYS C 88 N ASN C 51 SHEET 1 AA2 3 GLY A 122 GLU A 123 0 SHEET 2 AA2 3 ILE A 126 GLY A 129 -1 O ILE A 126 N GLU A 123 SHEET 3 AA2 3 GLY A 132 ASP A 135 -1 O VAL A 134 N ILE A 127 SHEET 1 AA3 2 GLY A 165 GLU A 167 0 SHEET 2 AA3 2 GLY B 202 TYR B 203 1 O GLY B 202 N GLU A 167 SHEET 1 AA4 2 LYS B 186 ILE B 187 0 SHEET 2 AA4 2 ILE C 172 GLU C 173 -1 O ILE C 172 N ILE B 187 SHEET 1 AA5 3 GLY B 212 SER B 213 0 SHEET 2 AA5 3 TRP B 206 ASN B 208 -1 N ASN B 208 O GLY B 212 SHEET 3 AA5 3 ASP F 3 VAL F 5 -1 O ALY F 4 N ARG B 207 SHEET 1 AA6 3 GLY C 122 GLU C 123 0 SHEET 2 AA6 3 ILE C 126 PHE C 128 -1 O ILE C 126 N GLU C 123 SHEET 3 AA6 3 PRO C 133 ASP C 135 -1 O VAL C 134 N ILE C 127 SHEET 1 AA7 3 GLY D 212 SER D 213 0 SHEET 2 AA7 3 TRP D 206 ASN D 208 -1 N ASN D 208 O GLY D 212 SHEET 3 AA7 3 ASP G 3 VAL G 5 -1 O ALY G 4 N ARG D 207 LINK SG CYS A 163 C ASP F 6 1555 1555 1.93 LINK SG CYS C 163 C ASP G 6 1555 1555 1.78 LINK C ACE F 1 N VAL F 2 1555 1555 1.33 LINK C ASP F 3 N ALY F 4 1555 1555 1.33 LINK C ALY F 4 N VAL F 5 1555 1555 1.33 LINK C ACE G 1 N VAL G 2 1555 1555 1.33 LINK C ASP G 3 N ALY G 4 1555 1555 1.34 LINK C ALY G 4 N VAL G 5 1555 1555 1.34 CRYST1 50.509 68.041 82.493 90.00 90.61 90.00 P 1 21 1 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.019798 0.000000 0.000210 0.00000 SCALE2 0.000000 0.014697 0.000000 0.00000 SCALE3 0.000000 0.000000 0.012123 0.00000